Nisa Investment Advisors
INMB icon

Nisa Investment Advisors’s INmune Bio INMB Stock Holding History

Nisa Investment Advisors’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-355
Closed -$820 – 3033
2025
Q2 		$820 Sell
355
-1,845
-84% -$13.5K ﹤0.01% 2775
2025
Q1 		$17.2K Buy
2,200
+1,969
+852% +$15.6K ﹤0.01% 1943
2024
Q4 		$1.08K Buy
231
+113
+96% +$589 ﹤0.01% 2663
2024
Q3 		$636 Buy
+118
New +$839 ﹤0.01% 2678

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nisa Investment Advisors's INMB Position: Q3 2025 in Review

Nisa Investment Advisors sold out of INmune Bio (INMB) in Q3 2025, closing a stake of 355 shares — an estimated $820 sold.

Nisa Investment Advisors first reported a position in INMB in Q3 2024 and held it in 4 quarters. The position peaked at $17.2K in Q1 2025. 73 funds tracked by Wall St. Rank hold INMB as of Q3 2025.

  • Nisa Investment Advisors reported no remaining INmune Bio position as of Q3 2025 after selling out during the quarter.
  • Nisa Investment Advisors sold 355 INmune Bio shares in Q3 2025, an estimated $820.
  • Nisa Investment Advisors first reported a position in INmune Bio in Q3 2024 and held it in 4 quarters.
  • Nisa Investment Advisors's INmune Bio position peaked at $17.2K in Q1 2025.
  • 73 funds tracked by Wall St. Rank held INmune Bio as of Q3 2025.

Based on Nisa Investment Advisors's 13F filing for Q3 2025, filed 23 Oct 2025.